A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, placebo-controlled, cross-over study will assess the effect of
aleglitazar on the pharmacokinetics and pharmacodynamics on Microgynon® in healthy
volunteers. Volunteers will receive multiple oral doses of aleglitazar in one period; in the
other period volunteers will receive placebo.